Join Now! /

Digital health platform Vinehealth raises $5.5m

Startacus RSS

by Startacus Admin

vinehealth image

Vinehealth secures major investment to support its mission of improving the quality of life and survival of cancer patients.

vinehealth appDigital health platform Vinehealth has just announced that it has raised $5.5m in seed funding in a round led by Talis Capital, with participation from previous investors Playfair Capital and Ascension and a number of angels.

Founded in 2018 by Rayna Patel and Georgina Kirby, the Vinehealth platform aims to improve the quality of life and outcomes of cancer patients. Using a combination of behavioural science and AI, the company’s intelligent digital technology provides highly scalable patient support programmes and collects rich data. Using Vinehealth’s app, patients can better self-manage their medications, side-effects and symptoms, and can regularly enter 'patient-reported outcome' (PRO) data to support clinical decision-making, inform service delivery and drive clinical research.  Uniquely, Vinehealth feeds this PRO data into its machine learning algorithms to drive even more personalised support to patients and further improve their outcomes. 

The Vinehealth app is rated 93% by ORCHA, the world’s largest single source of digital health compliance, making it the highest-rated cancer tool in the world by a significant margin. This builds on its award of a CE mark achieved in record time earlier this year; a significant regulatory milestone for the company.

The Vinehealth platform is set to scale rapidly across the life sciences sector, which is urgently in need of a scalable technology to drive richer patient insights, optimise patient engagement and improve therapeutic outcomes.

growwithgoogle2021_gili_8410This round of funding will be used to further develop its product, scale its team and expand in the US. The funding will also see Vinehealth’s board become 75% represented by females.

Speaking on the investment news, Rayna Patel, founder & CEO of Vinehealth, said : “We are delighted to have received such credible investor support to continue on our mission to empower and support those with cancer. It’s imperative that we start understanding how therapies are affecting patients: for pharmaceutical companies, our technology enables deeper patient understanding which leads to better drugs, greater differentiation and faster licensing, as well as the ability to provide personalised scalable support to patients. For patients, this means better care and improved outcomes from cancer. We’re now looking forward to applying our rich data and machine learning capabilities to novel predictive analytics to generate even richer insights for our life science partners.”

We have no doubt that we will be hearing a lot more about this innovative startup and the hugely important work it is doing.



Subscribe to our newsletter

If you would like to receive our startup themed newsletter, full of the latest startup opportunities, events, news, stories, tips and advice, then sign up here.
Startacus RSS
Business DealsSubmit Your Startup
Win TicketsNetwork and Collaborate
Our Latest Features

Published on: 7th December 2021

If you would like to enable commenting via your Startacus account, please enable Disqus functionality in your Account Settings.

Create an Idea!View Other Ideas, Projects or Startups
Why not Sign Up?
Create Projects
Edit Projects
Self Interviews
Self Starter of the Year
Product Giveaways
Subscribe to our Newsletter
Check us out at our Google+ page!